+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 1Week - 115Years
All Genders
ID00359684

Long-Term Monitoring and Treatment Evaluation of Cysteamine for Patients with Cystinosis

Led by National Human Genome Research Institute (NHGRI) · Updated on 2026-09-16

330

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to monitor patients with cystinosis, a rare inherited disease that causes poor growth and kidney failure due to cystine buildup in body cells. The study evaluates long-term effects of cysteamine treatment on patients, including detection of new complications and support for genetic testing. Cystinosis damages organs such as kidneys, thyroid, pancreas, eyes, and muscles, and this study helps understand its natural history through ongoing observation. Patients receive cysteamine, an oral medication that reduces cystine levels in white blood cells and muscle tissues. The study involves regular admissions to the NIH Clinical Center every two years, where patients undergo comprehensive testing to monitor cystine depletion and disease progression. This protocol has contributed to regulatory approval of cysteamine and provides valuable data on treatment outcomes and complications. During hospital admissions lasting one to three days, patients undergo various tests to assess cystine levels and health status. Researchers track the course of cystinosis and new complications in adults who may not have been well treated. Follow-up occurs every two years, allowing for long-term surveillance and knowledge sharing with the patient community. Participants may be involved for multiple decades, contributing to important insights about cystinosis and cysteamine therapy.

CONDITIONS

Brief Title

Use of Cysteamine in the Treatment of Cystinosis

Research Team

W

William A Gahl, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here